Literature DB >> 17574710

[Progressive multifocal leukoencephalopathy in a non-AIDS patient: high efficiency of combined cytarabine and cidofovir].

B Terrier1, A Hummel, F Fakhouri, M Jablonski, T Hügle, J Gasnault, M Sanson, F Martinez.   

Abstract

INTRODUCTION: Progressive multifocal leukoencephalopathy (PML) is an opportunistic infection of the central nervous system, occurring in immunocompromised patients. Treatment, not codified to date, is more often inefficient with a rapid and fatal deterioration. CASE RECORD: A 48-year-old woman, treated with immunosuppressant agents for systemic lupus, presented with PML mimicking neurolupus flare. A complete remission was obtained with cytarabine and cidofovir.
CONCLUSION: Combined cytarabine and cidofovir appears a promising therapeutic option in PML associated with autoimmune systemic disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17574710     DOI: 10.1016/j.revmed.2007.05.013

Source DB:  PubMed          Journal:  Rev Med Interne        ISSN: 0248-8663            Impact factor:   0.728


  6 in total

Review 1.  Diagnosis and Treatment of Progressive Multifocal Leukoencephalopathy Associated with Multiple Sclerosis Therapies.

Authors:  Eric M L Williamson; Joseph R Berger
Journal:  Neurotherapeutics       Date:  2017-10       Impact factor: 7.620

Review 2.  Molecular regulation of JC virus tropism: insights into potential therapeutic targets for progressive multifocal leukoencephalopathy.

Authors:  Leslie J Marshall; Eugene O Major
Journal:  J Neuroimmune Pharmacol       Date:  2010-04-17       Impact factor: 4.147

Review 3.  Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain.

Authors:  Michael W Ferenczy; Leslie J Marshall; Christian D S Nelson; Walter J Atwood; Avindra Nath; Kamel Khalili; Eugene O Major
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

4.  Systemic lupus erythematosus, progressive multifocal leukoencephalopathy, and T-CD4+ lymphopenia.

Authors:  Mariana Brandão; Joana Damásio; António Marinho; Ana Martins da Silva; Júlia Vasconcelos; Esmeralda Neves; Isabel Almeida; Fátima Farinha; Carlos Vasconcelos
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 10.817

5.  A case of developing progressive multifocal leukoencephalopathy while using rituximab and mycophenolate mofetil in refractory systemic lupus erythematosus.

Authors:  Yuichi Ishikawa; Tadamichi Kasuya; Junichi Ishikawa; Michio Fujiwara; Yasuhiko Kita
Journal:  Ther Clin Risk Manag       Date:  2018-06-26       Impact factor: 2.423

Review 6.  The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures.

Authors:  Erik De Clercq
Journal:  Med Res Rev       Date:  2011-01       Impact factor: 12.944

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.